Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91


Impact of the new MELD-based allocation system on waiting list and post-transplant survival - a cohort analysis using the French national CRISTAL database.

Jasseron C, Francoz C, Antoine C, Legeai C, Durand F, Dharancy S; collaborators.

Transpl Int. 2019 May 10. doi: 10.1111/tri.13448. [Epub ahead of print]


Hepatorenal Syndrome.

Francoz C, Durand F, Kahn JA, Genyk YS, Nadim MK.

Clin J Am Soc Nephrol. 2019 May 7;14(5):774-781. doi: 10.2215/CJN.12451018. Epub 2019 Apr 17.


Further to the Right: Piggyback Anastomosis on the Right Hepatic Vein Facilitates the Implantation of Small Liver Grafts (the One-vein Technique).

Le Roy B, Cauchy F, Cesaretti M, Sepulveda A, Yoh T, Dokmak S, Durand F, Weiss E, Francoz C, Dondero F, Soubrane O.

Ann Surg. 2019 May;269(5):e60-e62. doi: 10.1097/SLA.0000000000003039. No abstract available.


Assessment of renal function in cirrhosis: Sarcopenia, gender and ethnicity matter.

Francoz C, Sola E.

J Hepatol. 2019 May;70(5):828-830. doi: 10.1016/j.jhep.2019.02.004. Epub 2019 Mar 2. No abstract available.


Age and liver transplantation.

Durand F, Levitsky J, Cauchy F, Gilgenkrantz H, Soubrane O, Francoz C.

J Hepatol. 2019 Apr;70(4):745-758. doi: 10.1016/j.jhep.2018.12.009. Epub 2018 Dec 18. Review.


Hyperammonemic encephalopathy associated with hereditary hemorrhagic telangiectasia.

Dumortier J, Guillaud O, Erard-Poinsot D, Dupuis-Girod S, Francoz C, Durand F.

Clin Res Hepatol Gastroenterol. 2018 Nov 14. pii: S2210-7401(18)30227-4. doi: 10.1016/j.clinre.2018.10.011. [Epub ahead of print] No abstract available.


Modified technique of total hepatectomy in polycystic liver disease with caval flow preservation: the exposure left lateral sectionectomy.

Le Roy B, Cauchy F, Sepulveda A, Yoh T, Dokmak S, Weiss E, Cesaretti M, Durand F, Francoz C, Dondéro F, Soubrane O.

Transplantation. 2018 Nov 15. doi: 10.1097/TP.0000000000002538. [Epub ahead of print]


Endovascular Treatment of Arterial Complications After Liver Transplantation: Long-Term Follow-Up Evaluated on Doppler Ultrasound and Magnetic Resonance Cholangiopancreatography.

Breguet R, Dondero F, Pupulim L, Goossens N, Sepulveda A, Francoz C, Durand F, Terraz S, Vilgrain V, Ronot M.

Cardiovasc Intervent Radiol. 2019 Mar;42(3):381-388. doi: 10.1007/s00270-018-2108-8. Epub 2018 Nov 8.


Evidence for an Association Between Intrahepatic Vascular Changes and the Development of Hepatopulmonary Syndrome.

Lejealle C, Paradis V, Bruno O, de Raucourt E, Francoz C, Soubrane O, Lebrec D, Bedossa P, Valla D, Mal H, Vilgrain V, Durand F, Rautou PE.

Chest. 2019 Jan;155(1):123-136. doi: 10.1016/j.chest.2018.09.017. Epub 2018 Oct 4.


Hepatopulmonary syndrome-attributed extreme hypoxemia and polycythemia revealing liver cirrhosis.

Nuzzo A, Dautry R, Francoz C, Logeart D, Mégarbane B.

Am J Emerg Med. 2019 Jan;37(1):175.e1-175.e2. doi: 10.1016/j.ajem.2018.09.044. Epub 2018 Sep 26.


Further to the Right: Piggyback Anastomosis on the Right Hepatic Vein Facilitates the Implantation of Small Liver Grafts (The 1-vein Technique).

Le Roy B, Cauchy F, Cesaretti M, Sepulveda A, Yoh T, Dokmak S, Durand F, Weiss E, Francoz C, Dondéro F, Soubrane O.

Ann Surg. 2018 Sep 4. doi: 10.1097/SLA.0000000000003039. [Epub ahead of print] No abstract available.


Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.

Sérée O, Altieri M, Guillaume E, De Mil R, Lobbedez T, Robinson P, Segol P, Salamé E, Abergel A, Boillot O, Conti F, Chazouillères O, Debette-Gratien M, Debray D, Hery G, Dharancy S, Durand F, Duvoux C, Francoz C, Gugenheim J, Hardwigsen J, Houssel-Debry P, Jacquemin E, Kamar N, Latournerie M, Lebray P, Leroy V, Mazzola A, Neau-Cransac M, Pageaux GP, Radenne S, Saliba F, Samuel D, Vanlemmens C, Woehl-Jaegle ML, Launoy G, Dumortier J.

Liver Transpl. 2018 Oct;24(10):1425-1436. doi: 10.1002/lt.25310.


An outbreak of Pneumocytis jirovecii pneumonia among liver transplant recipients.

Miguel Montanes R, Elkrief L, Hajage D, Houssel P, Fantin B, Francoz C, Dreyfuss D, Ricard JD, Durand F.

Transpl Infect Dis. 2018 Oct;20(5):e12956. doi: 10.1111/tid.12956. Epub 2018 Jul 2.


Acute Kidney Injury After Liver Transplantation.

Durand F, Francoz C, Asrani SK, Khemichian S, Pham TA, Sung RS, Genyk YS, Nadim MK.

Transplantation. 2018 Oct;102(10):1636-1649. doi: 10.1097/TP.0000000000002305.


12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation.

Houssel-Debry P, Coilly A, Fougerou-Leurent C, Jezequel C, Duvoux C, De Ledinghen V, Radenne S, Kamar N, Leroy V, Martino VD, D'Alteroche L, Canva V, Conti F, Dumortier J, Montialoux H, Lebray P, Botta-Fridlund D, Tran A, Moreno C, Silvain C, Besch C, Perre P, Francoz C, Abergel A, Habersetzer F, Debette-Gratien M, Cagnot C, Diallo A, Chevaliez S, Rossignol E, Veislinger A, Duclos-Vallee JC, Pageaux GP; the ANRS CO23 CUPILT study group.

Hepatology. 2018 Oct;68(4):1277-1287. doi: 10.1002/hep.29918.


Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis.

Elkrief L, Ronot M, Andrade F, Dioguardi Burgio M, Issoufaly T, Zappa M, Roux O, Bissonnette J, Payancé A, Lebrec D, Francoz C, Soubrane O, Valla D, Durand F, Vilgrain V, Castera L, Rautou PE.

Aliment Pharmacol Ther. 2018 Mar;47(5):621-630. doi: 10.1111/apt.14488. Epub 2018 Jan 11.


Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.

Ziol M, Poté N, Amaddeo G, Laurent A, Nault JC, Oberti F, Costentin C, Michalak S, Bouattour M, Francoz C, Pageaux GP, Ramos J, Decaens T, Luciani A, Guiu B, Vilgrain V, Aubé C, Derman J, Charpy C, Zucman-Rossi J, Barget N, Seror O, Ganne-Carrié N, Paradis V, Calderaro J.

Hepatology. 2018 Jul;68(1):103-112. doi: 10.1002/hep.29762. Epub 2018 May 9.


Noninvasive assessment of liver steatosis in deceased donors: A pilot study.

Cesaretti M, Poté N, Cauchy F, Dondero F, Dokmak S, Sepulveda A, Schneck AS, Francoz C, Durand F, Paradis V, Soubrane O.

Liver Transpl. 2018 Apr;24(4):551-556. doi: 10.1002/lt.25002. No abstract available.


Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility.

Figorilli F, Putignano A, Roux O, Houssel-Debry P, Francoz C, Paugam-Burtz C, Soubrane O, Agarwal B, Durand F, Jalan R.

PLoS One. 2017 Dec 5;12(12):e0188151. doi: 10.1371/journal.pone.0188151. eCollection 2017.


Polycystic liver disease: Hepatic venous outflow obstruction lesions of the noncystic parenchyma have major consequences.

Barbier L, Ronot M, Aussilhou B, Cauchy F, Francoz C, Vilgrain V, Soubrane O, Paradis V, Belghiti J.

Hepatology. 2018 Aug;68(2):652-662. doi: 10.1002/hep.29582. Epub 2018 Jul 11.


Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study.

Dharancy S, Coilly A, Fougerou-Leurent C, Duvoux C, Kamar N, Leroy V, Tran A, Houssel-Debry P, Canva V, Moreno C, Conti F, Dumortier J, Di Martino V, Radenne S, De Ledinghen V, D'Alteroche L, Silvain C, Besch C, Perré P, Botta-Fridlund D, Francoz C, Habersetzer F, Montialoux H, Abergel A, Debette-Gratien M, Rohel A, Rossignol E, Samuel D, Duclos-Vallée JC, Pageaux GP; ANRS CO23 CUPILT study group.

Am J Transplant. 2017 Nov;17(11):2869-2878. doi: 10.1111/ajt.14490. Epub 2017 Oct 19.


Non selective beta blockers in cirrhosis.

Thalheimer U, Giannelli V, Francoz C, Maimone S.

J Hepatol. 2017 Dec;67(6):1342-1343. doi: 10.1016/j.jhep.2017.05.031. Epub 2017 Aug 5. No abstract available.


Estimation of the prevalence of intraductal papillary mucinous neoplasm of the pancreas in the French population through patients waiting for liver transplantation.

Laurent L, Vullierme MP, Rebours V, Maire F, Hentic O, Francoz C, Durand F, Ruszniewski P, Lévy P.

United European Gastroenterol J. 2017 Jun;5(4):499-503. doi: 10.1177/2050640616664842. Epub 2016 Aug 16.


Acute Liver Failure/Injury Related to Drug Reaction With Eosinophilia and Systemic Symptoms: Outcomes and Prognostic Factors.

Ichai P, Laurent-Bellue A, Saliba F, Moreau D, Besch C, Francoz C, Valeyrie-Allanore L, Bretagne SR, Boudon M, Antonini TM, Artru F, Pittau G, Roux O, Azoulay D, Levesque E, Durand F, Guettier C, Samuel D.

Transplantation. 2017 Aug;101(8):1830-1837. doi: 10.1097/TP.0000000000001655.


Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models.

Costentin CE, Amaddeo G, Decaens T, Boudjema K, Bachellier P, Muscari F, Salamé E, Bernard PH, Francoz C, Dharancy S, Vanlemmens C, Radenne S, Dumortier J, Hilleret MN, Chazouillères O, Pageaux GP, Calderaro J, Laurent A, Roudot-Thoraval F, Duvoux C; Liver Transplantation French Study Group.

Liver Int. 2017 May;37(5):717-726. doi: 10.1111/liv.13388. Epub 2017 Mar 24.


The future of liver transplantation for viral hepatitis.

Durand F, Francoz C.

Liver Int. 2017 Jan;37 Suppl 1:130-135. doi: 10.1111/liv.13310. Review.


Long-term outcome in liver transplantation candidates with portopulmonary hypertension.

Savale L, Sattler C, Coilly A, Conti F, Renard S, Francoz C, Bouvaist H, Feray C, Borentain P, Jaïs X, Montani D, Parent F, O'Connell C, Hervé P, Humbert M, Simonneau G, Samuel D, Calmus Y, Duvoux C, Durand F, Duclos-Vallée JC, Sitbon O.

Hepatology. 2017 May;65(5):1683-1692. doi: 10.1002/hep.28990. Epub 2017 Mar 14.


A Glycomics-Based Test Predicts the Development of Hepatocellular Carcinoma in Cirrhosis.

Verhelst X, Vanderschaeghe D, Castéra L, Raes T, Geerts A, Francoz C, Colman R, Durand F, Callewaert N, Van Vlierberghe H.

Clin Cancer Res. 2017 Jun 1;23(11):2750-2758. doi: 10.1158/1078-0432.CCR-16-1500. Epub 2016 Dec 16.


Correlation of tumor response on computed tomography with pathological necrosis in hepatocellular carcinoma treated by chemoembolization before liver transplantation.

Dioguardi Burgio M, Ronot M, Bruno O, Francoz C, Paradis V, Castera L, Durand F, Soubrane O, Vilgrain V.

Liver Transpl. 2016 Nov;22(11):1491-1500. doi: 10.1002/lt.24615.


Liver Transplantation With Older Donors: A Comparison With Younger Donors in a Context of Organ Shortage.

Barbier L, Cesaretti M, Dondero F, Cauchy F, Khoy-Ear L, Aoyagi T, Weiss E, Roux O, Dokmak S, Francoz C, Paugam-Burtz C, Sepulveda A, Belghiti J, Durand F, Soubrane O.

Transplantation. 2016 Nov;100(11):2410-2415.


Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation.

Dumortier J, Leroy V, Duvoux C, de Ledinghen V, Francoz C, Houssel-Debry P, Radenne S, d'Alteroche L, Fougerou-Leurent C, Canva V, di Martino V, Conti F, Kamar N, Moreno C, Lebray P, Tran A, Besch C, Diallo A, Rohel A, Rossignol E, Abergel A, Botta-Fridlund D, Coilly A, Samuel D, Duclos-Vallée JC, Pageaux GP.

Liver Transpl. 2016 Oct;22(10):1367-78. doi: 10.1002/lt.24505.


Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study.

Coilly A, Fougerou-Leurent C, de Ledinghen V, Houssel-Debry P, Duvoux C, Di Martino V, Radenne S, Kamar N, D'Alteroche L, Leroy V, Canva V, Lebray P, Moreno C, Dumortier J, Silvain C, Besch C, Perre P, Botta-Fridlund D, Anty R, Francoz C, Abergel A, Debette-Gratien M, Conti F, Habersetzer F, Rohel A, Rossignol E, Danjou H, Roque-Afonso AM, Samuel D, Duclos-Vallée JC, Pageaux GP; ANRS C023 CUPILT study group.

J Hepatol. 2016 Oct;65(4):711-718. doi: 10.1016/j.jhep.2016.05.039. Epub 2016 Jun 1.


Corrigendum to "Management of the critically ill patients with cirrhosis: A multidisciplinary perspective".

Nadim MK, Durand F, Kellum JA, Levitsky J, O'Leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-Tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent JL, Genyk YS.

J Hepatol. 2016 May 27. pii: S0168-8278(16)30185-4. doi: 10.1016/j.jhep.2016.05.001. [Epub ahead of print] No abstract available.


Kidney biomarkers in cirrhosis.

Francoz C, Nadim MK, Durand F.

J Hepatol. 2016 Oct;65(4):809-824. doi: 10.1016/j.jhep.2016.05.025. Epub 2016 May 26. Review.


Liver transplantation for hepatocellular carcinoma: is zero recurrence theoretically possible?

Irtan S, Barbier L, Francoz C, Dondero F, Durand F, Belghiti J.

Hepatobiliary Pancreat Dis Int. 2016 Apr;15(2):147-51.


Lack of clinical or haemodynamic rebound after abrupt interruption of beta-blockers in patients with cirrhosis.

Payancé A, Bissonnette J, Roux O, Elkrief L, Gault N, Francoz C, Nekachtali O, Soubrane O, Lebrec D, Valla D, Durand F, Rautou PE.

Aliment Pharmacol Ther. 2016 May;43(9):966-73. doi: 10.1111/apt.13577. Epub 2016 Mar 1.


Rare and transient anti-D antibody response in D(-) liver transplant recipients transfused with D(+) red blood cells.

Burin des Roziers N, Ibanez C, Samuel D, Francoz C, Idri S, François A, Mortelecque R, Bierling P, Pirenne F.

Vox Sang. 2016 Jul;111(1):107-10. doi: 10.1111/vox.12392. Epub 2016 Feb 25.


Management of the critically ill patient with cirrhosis: A multidisciplinary perspective.

Nadim MK, Durand F, Kellum JA, Levitsky J, O'Leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-Tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent JL, Genyk YS.

J Hepatol. 2016 Mar;64(3):717-35. doi: 10.1016/j.jhep.2015.10.019. Epub 2015 Oct 28. Review. No abstract available.


Assessment of adrenal function in patients with acute hepatitis using serum free and total cortisol.

Degand T, Monnet E, Durand F, Grandclement E, Ichai P, Borot S, Qualls CR, Agin A, Louvet A, Dumortier J, Francoz C, Dumoulin G, Di Martino V, Dorin R, Thevenot T.

Dig Liver Dis. 2015 Sep;47(9):783-9. doi: 10.1016/j.dld.2015.05.016. Epub 2015 May 22.


Characteristics of vertebral osteomyelitis after liver transplantation.

Buzelé R, Zarrouk V, Francoz C, Durand F, Fantin B.

Clin Microbiol Infect. 2015 Jun;21(6):573-7. doi: 10.1016/j.cmi.2015.01.018. Epub 2015 Jan 28.


Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria.

Ichai P, Legeai C, Francoz C, Boudjema K, Boillot O, Ducerf C, Mathurin P, Pruvot FR, Suc B, Wolf P, Soubrane O, Le Treut YP, Cherqui D, Hannoun L, Pageaux GP, Gugenheim J, Letoublon C, Saric J, Di Martino V, Abergel A, Chiche L, Antonini TM, Jacquelinet C, Castaing D, Samuel D; French Liver Transplant Teams.

Liver Transpl. 2015 Apr;21(4):512-23. doi: 10.1002/lt.24092.


Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis.

Elkrief L, Rautou PE, Ronot M, Lambert S, Dioguardi Burgio M, Francoz C, Plessier A, Durand F, Valla D, Lebrec D, Vilgrain V, Castéra L.

Radiology. 2015 May;275(2):589-98. doi: 10.1148/radiol.14141210. Epub 2014 Nov 28.


Interactions between virus-related factors and post-transplant ascites in patients with hepatitis C and no cirrhosis: role of cryoglobulinemia.

Tripon S, Francoz C, Albuquerque A, Paradis V, Boudjema H, Voitot H, Belghiti J, Valla D, Durand F.

Transpl Int. 2015 Feb;28(2):162-9. doi: 10.1111/tri.12466. Epub 2014 Nov 19.


Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C.

Elkrief L, Chouinard P, Bendersky N, Hajage D, Larroque B, Babany G, Kutala B, Francoz C, Boyer N, Moreau R, Durand F, Marcellin P, Rautou PE, Valla D.

Hepatology. 2014 Sep;60(3):823-31. doi: 10.1002/hep.27228. Epub 2014 Jul 29.


Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography.

Durand F, Buyse S, Francoz C, Laouénan C, Bruno O, Belghiti J, Moreau R, Vilgrain V, Valla D.

J Hepatol. 2014 Jun;60(6):1151-7. doi: 10.1016/j.jhep.2014.02.026. Epub 2014 Mar 6.


Type-1 hepatorenal syndrome in patients with cirrhosis and infection vs. sepsis-induced acute kidney injury: what matters?

Francoz C, Durand F.

J Hepatol. 2014 May;60(5):907-9. doi: 10.1016/j.jhep.2014.02.001. Epub 2014 Feb 6. No abstract available.


Portomesenteric shunt for liver transplantation and complete portal vein thrombosis.

Dokmak S, Aussilhou B, Dondéro F, Francoz C, Durand F, Belghiti J.

Transplantation. 2013 Nov 27;96(10):e68-9. doi: 10.1097/01.TP.0000435700.76890.65. No abstract available.


Type 2 diabetes mellitus as a risk factor for intestinal resection in patients with superior mesenteric vein thrombosis.

Elkrief L, Corcos O, Bruno O, Larroque B, Rautou PE, Zekrini K, Bretagnol F, Joly F, Francoz C, Bondjemah V, Cazals-Hatem D, Boudaoud L, De Raucourt E, Panis Y, Goria O, Hillaire S, Valla D, Plessier A.

Liver Int. 2014 Oct;34(9):1314-21. doi: 10.1111/liv.12386. Epub 2013 Dec 3.


Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations.

Francoz C, Nadim MK, Baron A, Prié D, Antoine C, Belghiti J, Valla D, Moreau R, Durand F.

Hepatology. 2014 Apr;59(4):1514-21. doi: 10.1002/hep.26704. Epub 2014 Mar 3.


Liver resection in transplanted patients: a single-center Western experience.

Sommacale D, Dondero F, Sauvanet A, Francoz C, Durand F, Farges O, Kianmanesh R, Belghiti J.

Transplant Proc. 2013 Sep;45(7):2726-8. doi: 10.1016/j.transproceed.2013.07.032.


Supplemental Content

Loading ...
Support Center